A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study will evaluate the maximum safe dose of the true human monoclonal antibody, 514G3, in the treatment of patients with Staphylococcus Aureus bacteremia. Preliminary evidence of efficacy will be evaluated as well. Patients will receive 514G3 plus antibiotics or placebo plus antibiotics in approximately a 3 to 1 ratio.
Epistemonikos ID: be2ae89db0f1a0b5ed5f883adb5291026a279637
First added on: May 12, 2024